Holen Sie sich die Stockscreener-App
1.87
1.91%
0.04
Handel nachbörslich:
1.89
0.02
+1.07%
Schlusskurs vom Vortag:
$1.83
Offen:
$1.8
24-Stunden-Volumen:
251.28K
Relative Volume:
0.19
Marktkapitalisierung:
$49.71M
Einnahmen:
$155.00K
Nettoeinkommen (Verlust:
$-30.01M
KGV:
-1.1198
EPS:
-1.67
Netto-Cashflow:
$-11.98M
1W Leistung:
-4.85%
1M Leistung:
-7.21%
6M Leistung:
-75.33%
1J Leistung:
-63.29%
1-Tages-Spanne:
$1.7847
$1.90
1-Wochen-Bereich:
$1.7847
$2.0492
52-Wochen-Spanne:
$1.71
$11.64
Inmune Bio Inc Stock (INMB) Company Profile
Firmenname
Inmune Bio Inc
Sektor
Branche
Telefon
(858) 964-3720
Adresse
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
Vergleichen Sie INMB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INMB
Inmune Bio Inc
|
1.87 | 48.65M | 155.00K | -30.01M | -11.98M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-01 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-07-01 | Herabstufung | Scotiabank | Sector Outperform → Sector Underperform |
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-10-21 | Eingeleitet | Alliance Global Partners | Buy |
| 2024-09-27 | Eingeleitet | Raymond James | Outperform |
| 2024-08-22 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-06-01 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-05-24 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-07-07 | Bestätigt | Maxim Group | Buy |
| 2021-04-21 | Eingeleitet | B. Riley Securities | Buy |
| 2021-01-22 | Bestätigt | Maxim Group | Buy |
| 2020-09-01 | Eingeleitet | BTIG Research | Buy |
| 2020-07-15 | Bestätigt | H.C. Wainwright | Buy |
Alle ansehen
Inmune Bio Inc Aktie (INMB) Neueste Nachrichten
INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025 - The Manila Times
Oct 22 CEO Panel: INmune Bio's CORDStrom for RDEB — David Moss at Maxim Growth Summit in NYC - Stock Titan
Will INmune Bio Inc. stock outperform tech sector in 20252025 Bull vs Bear & Daily Entry Point Trade Alerts - newser.com
Is it time to cut losses on INmune Bio Inc.Trade Volume Report & Reliable Volume Spike Trade Alerts - newser.com
Can volume confirm reversal in INmune Bio Inc.July 2025 Closing Moves & Weekly Market Pulse Alerts - newser.com
Sector ETF performance correlation with INmune Bio Inc.Market Sentiment Report & Free Low Drawdown Momentum Trade Ideas - newser.com
How INmune Bio Inc. stock benefits from global expansionInsider Selling & Daily Market Momentum Tracking - newser.com
INmune Bio Inc Stock Analysis and ForecastCandlestick Trading Patterns & Free Rapid Profit Acceleration - earlytimes.in
INmune Bio Inc. stock trend outlook and recovery pathMarket Risk Analysis & High Accuracy Swing Entry Alerts - newser.com
How to track smart money flows in INmune Bio Inc.July 2025 EndofMonth & Reliable Trade Execution Plans - newser.com
What does recent volatility data suggest for INmune Bio Inc.Portfolio Performance Summary & AI Driven Price Forecasts - newser.com
INmune Bio (NASDAQ:INMB) Receives "Sell (E+)" Rating from Weiss Ratings - MarketBeat
INmune Bio, Inc. (NASDAQ:INMB) Receives Average Rating of "Hold" from Analysts - MarketBeat
Using RSI to spot recovery in INmune Bio Inc.Market Weekly Review & Weekly High Conviction Ideas - newser.com
Analyzing INmune Bio Inc. with risk reward ratio chartsGDP Growth & Safe Capital Growth Tips - newser.com
Predicting INmune Bio Inc. trend using moving averagesJuly 2025 Action & Target Return Focused Picks - newser.com
Inmune Bio Submits Manuscript on Alzheimer’s Trial - TipRanks
INmune Bio submits manuscript on Phase 2 Alzheimer’s trial results - Investing.com
Inmune Bio announces submission of phase 2 mindful trial results in Alzheimer's - MarketScreener
INmune Bio submits manuscript on Phase 2 Alzheimer’s trial results By Investing.com - Investing.com Australia
INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer’s Disease to npj Dementia, a Nature Portfolio Journal - Yahoo Finance
What analysts say about INmune Bio Inc stockTechnical Breakout Signals & Free Daily Stock Hotspot Analysis - Early Times
AI Stocks: Whats the profit margin of INmune Bio IncJuly 2025 Retail & Community Consensus Stock Picks - خودرو بانک
Analysis Recap: Is INmune Bio Inc. forming a double bottomEarnings Summary Report & Fast Moving Market Watchlists - خودرو بانک
INmune Bio, Inc. (NASDAQ:INMB) Short Interest Update - MarketBeat
Aug Macro: Whats the profit margin of INmune Bio IncEarnings Risk Summary & High Accuracy Trade Alerts - khodrobank.com
How does Battalion Oil Corporation compare to its peersWeekly Investment Report & AI Enhanced Trading Signals - khodrobank.com
INmune Bio, Inc. (NASDAQ:INMB) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Risk Analysis: Can INmune Bio Inc stock outperform in a bear marketJuly 2025 Sector Moves & Daily Volume Surge Trade Alerts - خودرو بانک
Will INmune Bio Inc outperform the market in YEAR2025 Biggest Moves & Weekly Stock Performance Updates - خودرو بانک
Block Trades: What are INmune Bio Incs earnings expectationsQuarterly Growth Report & Safe Entry Zone Identification - khodrobank.com
Has INmune Bio Inc. formed a bullish divergenceJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com
Retail Surge: Is INmune Bio Inc a stock for growth or value investorsQuarterly Investment Review & AI Driven Stock Reports - خودرو بانک
Aug Macro: Is INmune Bio Inc. impacted by rising rates2025 Geopolitical Influence & AI Based Trade Execution Alerts - خودرو بانک
INmune Bio, Inc. (NASDAQ:INMB) Receives $18.40 Consensus PT from Analysts - Defense World
Loss Report: Can INmune Bio Inc stock outperform in a bear marketWeekly Profit Analysis & Scalable Portfolio Growth Methods - خودرو بانک
VIX Spike: Is INmune Bio Inc stock undervalued right nowJuly 2025 Rallies & Reliable Trade Execution Plans - خودرو بانک
Meme Stocks: How is i 80 Gold Corp managing supply chain issuesEarnings Summary Report & Daily Chart Pattern Signal Reports - خودرو بانک
Aug Summary: Will INmune Bio Inc benefit from geopolitical trendsJuly 2025 EndofMonth & Capital Efficient Trade Techniques - خودرو بانک
Aug Outlook: Is INmune Bio Inc a stock for growth or value investorsJuly 2025 Chart Watch & Accurate Intraday Trade Tips - khodrobank.com
Breakout Move: Can INmune Bio Inc expand into new marketsInsider Buying & Risk Adjusted Buy/Sell Alerts - خودرو بانک
Bearish Setup: Is INmune Bio Inc stock a value trapNew Guidance & Weekly Breakout Opportunity Watchlist - خودرو بانک
Risks Report: Is INmune Bio Inc. stock a falling knife or bargain buyWeekly Investment Summary & Accurate Entry and Exit Point Alerts - خودرو بانک
Finanzdaten der Inmune Bio Inc-Aktie (INMB)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):